Literature DB >> 11834619

Pirlindole and dehydropirlindole protect rat cultured neuronal cells against oxidative stress-induced cell death through a mechanism unrelated to MAO-A inhibition.

A Boland1, J Gérardy, D Mossay, D Delapierre, V Seutin.   

Abstract

It has been shown that the MAO (monoamine oxidase)-B inhibitor deprenyl (DPR, selegiline) protects some cell types against oxidative stress. By decreasing H(2)O(2) production, MAO-A inhibitors could also reduce oxidative stress. This study reports the effect of the MAO-A inhibitors, pirlindole (PIR), dehydropirlindole (DHP), brofaromine (BRO) and moclobemide (MCL) on primary-cultured brain cells exposed to iron-mediated toxicity. A comparison with trolox (TRO), a hydrosoluble vitamin-E analogue that protects against such an induced stress, was performed. Rat hippocampal or cortical cultured cells were exposed either to 2 microM FeSO(4) alone or in the presence of PIR, DHP, BRO, DPR, MCL or TRO. Cell survival (lactate-dehydrogenase measurements, 16 h incubation), intracellular peroxide production (DCF-fluorescence, 1 h incubation), lipoperoxidation (TBARS-fluorescence, 6 h incubation) and mitochondrial function (MTT-test, 16 h incubation) were assessed. PIR, DHP and TRO significantly protected cultures (P<0.05) against Fe(2+)-induced toxicity in a concentration-dependent manner. The EC(50s) of these compounds were 6, 12 and 19 microM, respectively, in hippocampal cells. For cortical cell cultures incubated in the presence of iron and PIR or DHP, EC(50s) were 5 and 6 microM respectively. All Hill coefficients were close to unity. BRO, MCL and DPR were not protective in any type of culture. The IC(50s) for the inhibition of MAO-A were 2, 2 and 0.2 microM for PIR, DHP and BRO, respectively. PIR, DHP and TRO, but not DPR, induced a significant decrease in both intracellular peroxide production and lipoperoxidation. They also improved mitochondrial function. These experiments show that PIR and DHP can protect hippocampal and cortical neurons against oxidative stress at pharmacologically relevant concentrations. This protective effect seems unrelated to inhibition of MAO-A, but possibly involves free radical scavenging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834619      PMCID: PMC1573183          DOI: 10.1038/sj.bjp.0704519

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.

Authors:  D Praticò; N Delanty
Journal:  Am J Med       Date:  2000-11       Impact factor: 4.965

2.  Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain.

Authors:  L W Thorpe; K N Westlund; L M Kochersperger; C W Abell; R M Denney
Journal:  J Histochem Cytochem       Date:  1987-01       Impact factor: 2.479

3.  Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

Authors:  M Da Prada; R Kettler; H H Keller; W P Burkard; D Muggli-Maniglio; W E Haefely
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

4.  A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase.

Authors:  S H Snyder; E D Hendley
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

Review 6.  Molecular basis of human MAO A and B.

Authors:  J C Shih
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

7.  Propofol protects cultured brain cells from iron ion-induced death: comparison with trolox.

Authors:  A Boland; D Delapierre; D Mossay; P Hans; A Dresse
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

8.  Antioxidant activity of the monoamine oxidase B inhibitor lazabemide.

Authors:  R P Mason; E G Olmstead; R F Jacob
Journal:  Biochem Pharmacol       Date:  2000-09-01       Impact factor: 5.858

9.  Comparative effects of dehydropirlindole and other compounds on rat brain monoamine oxidase type A.

Authors:  Jean Gerardy; Albert Dresse
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

10.  Oxidative stress, mitochondrial respiration, and Parkinson's disease.

Authors:  G Cohen
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

View more
  4 in total

1.  Knocking down of the KCC2 in rat hippocampal neurons increases intracellular chloride concentration and compromises neuronal survival.

Authors:  Christophe Pellegrino; Olena Gubkina; Michael Schaefer; Hélène Becq; Anastasia Ludwig; Marat Mukhtarov; Ilona Chudotvorova; Severine Corby; Yuriy Salyha; Sergey Salozhin; Piotr Bregestovski; Igor Medina
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

2.  Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture.

Authors:  A M Bielecka; M Paul-Samojedny; E Obuchowicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-02       Impact factor: 3.000

3.  Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Zhu-Ming Zhang; Pentti M Rautaharju; Ronald J Prineas; Carlos J Rodriguez; Laura Loehr; Wayne D Rosamond; Dalane Kitzman; David Couper; Elsayed Z Soliman
Journal:  Circulation       Date:  2016-05-16       Impact factor: 29.690

4.  Structure Prediction and Potential Inhibitors Docking of Enterovirus 2C Proteins.

Authors:  Daoqun Li; Leiliang Zhang
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.